GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Teleflex Inc (BSP:T1FX34) » Definitions » Total Liabilities

Teleflex (BSP:T1FX34) Total Liabilities : R$14,813 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Teleflex Total Liabilities?

Teleflex's Total Liabilities for the quarter that ended in Mar. 2024 was R$14,813 Mil.

Teleflex's quarterly Total Liabilities declined from Sep. 2023 (R$15,703.02 Mil) to Dec. 2023 (R$15,148.02 Mil) and declined from Dec. 2023 (R$15,148.02 Mil) to Mar. 2024 (R$14,813.47 Mil).

Teleflex's annual Total Liabilities declined from Dec. 2021 (R$17,626.18 Mil) to Dec. 2022 (R$15,243.63 Mil) and declined from Dec. 2022 (R$15,243.63 Mil) to Dec. 2023 (R$15,148.02 Mil).


Teleflex Total Liabilities Historical Data

The historical data trend for Teleflex's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teleflex Total Liabilities Chart

Teleflex Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13,670.04 19,632.70 17,626.18 15,243.63 15,148.02

Teleflex Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14,624.03 13,010.99 15,703.02 15,148.02 14,813.47

Teleflex Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Teleflex's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2972.929+(9010.105+812.74
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+2234.701+117.541)
=15,148

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=36907.969-21759.953
=15,148

Teleflex's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2843.536+(8825.56+756.392
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+2272.601+115.382)
=14,813

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=37238.556-22425.085
=14,813

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Teleflex Total Liabilities Related Terms

Thank you for viewing the detailed overview of Teleflex's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Teleflex (BSP:T1FX34) Business Description

Traded in Other Exchanges
Address
550 East Swedesford Road, Suite 400, Wayne, PA, USA, 19087
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2022 sales), interventional (16%), anesthesia (14%), surgical (14%), interventional urology (12%), original-equipment manufacturing (10%), and all other (10%). Geographic exposure for the business is primarily in the U.S., which accounts for 60% of revenue, with international markets making up the remainder.

Teleflex (BSP:T1FX34) Headlines

No Headlines